User login
The Global Impact of Respiratory Disease – Second Edition
The Global Impact of Respiratory Disease – Second Edition was released by the Forum of International Respiratory Societies (FIRS) at the World Health Assembly May 25, 2017, in Geneva, Switzerland, calling attention to the global burden of lung disease and the benefits of prevention and clean air.
We often take our breathing and our respiratory health for granted, but respiratory diseases are a leading cause of death and disability in the world. Sixty-five million people suffer from COPD, and 3 million die of it each year, now making it the third leading cause of death worldwide.1,2 Asthma affects 334 million people in the world and is the most common chronic disease of childhood.3 Pneumonia kills millions of people annually and is a leading cause of death among children under 5 years old.4 Over 10 million people develop TB, and 1.4 million die of it each year, making it the most common deadly infectious disease.5 Lung cancer kills 1.6 million people each year and is the most deadly cancer.6 Globally, at least 2 billion people are exposed to indoor toxic smoke, 1 billion inhale outdoor pollutant air, and 1 billion are exposed to tobacco smoke. Many of us, and the world, are naïve to these staggering realities.
The American College of Chest Physicians® (CHEST), together with FIRS, is working hard to change these realities. CHEST, and our more than 19,000 members around the world, want a better future, one that has less suffering. We want a future that enables and allows everyone to breathe freely.
The 2017 Global Impact of Respiratory Disease report objectively speaks to these issues and outlines an eight-step action plan to impact these serious concerns. It highlights the importance of prevention, control, and cure of these diseases and announces that promotion of respiratory health must be a top priority for health-care systems and decision-makers. In emphasizing that these goals are achievable, it also highlights the reality that the prevention and cure of respiratory diseases are among the most cost-effective health interventions available – a “best-buy” in the view of the World Health Organization (WHO). In addition to reducing so much suffering, investment in respiratory health will pay manifold dividends in longevity, healthy living days, and national economies.
Darcy Marciniuk, MD, FCCP, FRCPC, and Co-Chair of the Report notes, “The Global Impact of Respiratory Disease” report calls attention to the importance of respiratory health in the world. The report and these efforts are required to ensure respiratory health becomes a top priority in global decision-making.”
In addition to focusing attention to the importance of respiratory health in the world and ensuring it becomes a global priority, the 2017 Global Impact of Respiratory Disease report also includes practical information for our members. The report summarizes the current state of our understanding with the “Big 5”: COPD, asthma, pneumonia, lung cancer, and TB, as well as with the environment and clean air, sleep-disordered breathing, pulmonary hypertension, and pulmonary embolism. It highlights key controllable factors, such as a reduction in tobacco smoking and improvement in air quality, which includes reduction in second-hand tobacco smoke, smoke from indoor fire, and unhealthy public and workplace air. The report underlines the value of trained health-care professionals and the need for health-care systems and policies to support those trained professionals. Finally, it emphasizes the reality that investment in respiratory research is more than the hope for today – it is the promise and a genuine commitment for tomorrow. CHEST’s involvement in this important project is only one component of our global engagement and impact. We support and help to educate lung specialists and health-care teams, no matter where they live and work. Our journal CHEST®, and other education offerings, are used every day and in every part of the world. The American College of Chest Physicians® focuses on the prevention, diagnosis, and treatment of chest diseases by providing innovative education and advancing best patient outcomes around the globe.
About the Forum of International Respiratory Societies (FIRS) Formed in 2001, the Forum of International Respiratory Societies (FIRS) is composed of the leading international respiratory societies, with more than 70,000 members who devote their working lives to respiratory health and disease. The goal of FIRS is to speak with one voice in promoting respiratory health worldwide and to call for action to reduce, prevent, cure, and control the terrible burden of respiratory disease.
References
1. World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases, a comprehensive approach. 2007.
2. Burney PG, Patel J, Newson R, et al. Global and regional trends in COPD mortality, 1990-2010. Eur Respir J. 2015;45(5):1239-47.
3. International Study of Asthma and Allergies in Childhood (ISAAC). Global Asthma Report. 2014.
4. World Health Organization. Pneumonia: the forgotten killer of children. Geneva: World Health Organization; 2006.
5. World Health Organization. Global Tuberculosis Report 2016. Geneva: World Health Organization; 2016.
6. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108.
The Global Impact of Respiratory Disease – Second Edition was released by the Forum of International Respiratory Societies (FIRS) at the World Health Assembly May 25, 2017, in Geneva, Switzerland, calling attention to the global burden of lung disease and the benefits of prevention and clean air.
We often take our breathing and our respiratory health for granted, but respiratory diseases are a leading cause of death and disability in the world. Sixty-five million people suffer from COPD, and 3 million die of it each year, now making it the third leading cause of death worldwide.1,2 Asthma affects 334 million people in the world and is the most common chronic disease of childhood.3 Pneumonia kills millions of people annually and is a leading cause of death among children under 5 years old.4 Over 10 million people develop TB, and 1.4 million die of it each year, making it the most common deadly infectious disease.5 Lung cancer kills 1.6 million people each year and is the most deadly cancer.6 Globally, at least 2 billion people are exposed to indoor toxic smoke, 1 billion inhale outdoor pollutant air, and 1 billion are exposed to tobacco smoke. Many of us, and the world, are naïve to these staggering realities.
The American College of Chest Physicians® (CHEST), together with FIRS, is working hard to change these realities. CHEST, and our more than 19,000 members around the world, want a better future, one that has less suffering. We want a future that enables and allows everyone to breathe freely.
The 2017 Global Impact of Respiratory Disease report objectively speaks to these issues and outlines an eight-step action plan to impact these serious concerns. It highlights the importance of prevention, control, and cure of these diseases and announces that promotion of respiratory health must be a top priority for health-care systems and decision-makers. In emphasizing that these goals are achievable, it also highlights the reality that the prevention and cure of respiratory diseases are among the most cost-effective health interventions available – a “best-buy” in the view of the World Health Organization (WHO). In addition to reducing so much suffering, investment in respiratory health will pay manifold dividends in longevity, healthy living days, and national economies.
Darcy Marciniuk, MD, FCCP, FRCPC, and Co-Chair of the Report notes, “The Global Impact of Respiratory Disease” report calls attention to the importance of respiratory health in the world. The report and these efforts are required to ensure respiratory health becomes a top priority in global decision-making.”
In addition to focusing attention to the importance of respiratory health in the world and ensuring it becomes a global priority, the 2017 Global Impact of Respiratory Disease report also includes practical information for our members. The report summarizes the current state of our understanding with the “Big 5”: COPD, asthma, pneumonia, lung cancer, and TB, as well as with the environment and clean air, sleep-disordered breathing, pulmonary hypertension, and pulmonary embolism. It highlights key controllable factors, such as a reduction in tobacco smoking and improvement in air quality, which includes reduction in second-hand tobacco smoke, smoke from indoor fire, and unhealthy public and workplace air. The report underlines the value of trained health-care professionals and the need for health-care systems and policies to support those trained professionals. Finally, it emphasizes the reality that investment in respiratory research is more than the hope for today – it is the promise and a genuine commitment for tomorrow. CHEST’s involvement in this important project is only one component of our global engagement and impact. We support and help to educate lung specialists and health-care teams, no matter where they live and work. Our journal CHEST®, and other education offerings, are used every day and in every part of the world. The American College of Chest Physicians® focuses on the prevention, diagnosis, and treatment of chest diseases by providing innovative education and advancing best patient outcomes around the globe.
About the Forum of International Respiratory Societies (FIRS) Formed in 2001, the Forum of International Respiratory Societies (FIRS) is composed of the leading international respiratory societies, with more than 70,000 members who devote their working lives to respiratory health and disease. The goal of FIRS is to speak with one voice in promoting respiratory health worldwide and to call for action to reduce, prevent, cure, and control the terrible burden of respiratory disease.
References
1. World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases, a comprehensive approach. 2007.
2. Burney PG, Patel J, Newson R, et al. Global and regional trends in COPD mortality, 1990-2010. Eur Respir J. 2015;45(5):1239-47.
3. International Study of Asthma and Allergies in Childhood (ISAAC). Global Asthma Report. 2014.
4. World Health Organization. Pneumonia: the forgotten killer of children. Geneva: World Health Organization; 2006.
5. World Health Organization. Global Tuberculosis Report 2016. Geneva: World Health Organization; 2016.
6. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108.
The Global Impact of Respiratory Disease – Second Edition was released by the Forum of International Respiratory Societies (FIRS) at the World Health Assembly May 25, 2017, in Geneva, Switzerland, calling attention to the global burden of lung disease and the benefits of prevention and clean air.
We often take our breathing and our respiratory health for granted, but respiratory diseases are a leading cause of death and disability in the world. Sixty-five million people suffer from COPD, and 3 million die of it each year, now making it the third leading cause of death worldwide.1,2 Asthma affects 334 million people in the world and is the most common chronic disease of childhood.3 Pneumonia kills millions of people annually and is a leading cause of death among children under 5 years old.4 Over 10 million people develop TB, and 1.4 million die of it each year, making it the most common deadly infectious disease.5 Lung cancer kills 1.6 million people each year and is the most deadly cancer.6 Globally, at least 2 billion people are exposed to indoor toxic smoke, 1 billion inhale outdoor pollutant air, and 1 billion are exposed to tobacco smoke. Many of us, and the world, are naïve to these staggering realities.
The American College of Chest Physicians® (CHEST), together with FIRS, is working hard to change these realities. CHEST, and our more than 19,000 members around the world, want a better future, one that has less suffering. We want a future that enables and allows everyone to breathe freely.
The 2017 Global Impact of Respiratory Disease report objectively speaks to these issues and outlines an eight-step action plan to impact these serious concerns. It highlights the importance of prevention, control, and cure of these diseases and announces that promotion of respiratory health must be a top priority for health-care systems and decision-makers. In emphasizing that these goals are achievable, it also highlights the reality that the prevention and cure of respiratory diseases are among the most cost-effective health interventions available – a “best-buy” in the view of the World Health Organization (WHO). In addition to reducing so much suffering, investment in respiratory health will pay manifold dividends in longevity, healthy living days, and national economies.
Darcy Marciniuk, MD, FCCP, FRCPC, and Co-Chair of the Report notes, “The Global Impact of Respiratory Disease” report calls attention to the importance of respiratory health in the world. The report and these efforts are required to ensure respiratory health becomes a top priority in global decision-making.”
In addition to focusing attention to the importance of respiratory health in the world and ensuring it becomes a global priority, the 2017 Global Impact of Respiratory Disease report also includes practical information for our members. The report summarizes the current state of our understanding with the “Big 5”: COPD, asthma, pneumonia, lung cancer, and TB, as well as with the environment and clean air, sleep-disordered breathing, pulmonary hypertension, and pulmonary embolism. It highlights key controllable factors, such as a reduction in tobacco smoking and improvement in air quality, which includes reduction in second-hand tobacco smoke, smoke from indoor fire, and unhealthy public and workplace air. The report underlines the value of trained health-care professionals and the need for health-care systems and policies to support those trained professionals. Finally, it emphasizes the reality that investment in respiratory research is more than the hope for today – it is the promise and a genuine commitment for tomorrow. CHEST’s involvement in this important project is only one component of our global engagement and impact. We support and help to educate lung specialists and health-care teams, no matter where they live and work. Our journal CHEST®, and other education offerings, are used every day and in every part of the world. The American College of Chest Physicians® focuses on the prevention, diagnosis, and treatment of chest diseases by providing innovative education and advancing best patient outcomes around the globe.
About the Forum of International Respiratory Societies (FIRS) Formed in 2001, the Forum of International Respiratory Societies (FIRS) is composed of the leading international respiratory societies, with more than 70,000 members who devote their working lives to respiratory health and disease. The goal of FIRS is to speak with one voice in promoting respiratory health worldwide and to call for action to reduce, prevent, cure, and control the terrible burden of respiratory disease.
References
1. World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases, a comprehensive approach. 2007.
2. Burney PG, Patel J, Newson R, et al. Global and regional trends in COPD mortality, 1990-2010. Eur Respir J. 2015;45(5):1239-47.
3. International Study of Asthma and Allergies in Childhood (ISAAC). Global Asthma Report. 2014.
4. World Health Organization. Pneumonia: the forgotten killer of children. Geneva: World Health Organization; 2006.
5. World Health Organization. Global Tuberculosis Report 2016. Geneva: World Health Organization; 2016.
6. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108.
Making it Personal Through a Career of Service
Ronald M. Fairman, MD, held center stage Friday to present his presidential address, highlighting the personal side of vascular surgery and a career of service.
After acknowledging his family, friends, mentors, the international surgeon community, and his “family” at the University of Pennsylvania, he took the audience on “an abbreviated journey” to share events he hoped would resonate.
“Yes, it is true I was born at Penn and I am still there,” he joked. A rotation on the Penn Vascular Service led him to vascular surgery. “I was drawn to many aspects of the specialty: really sick patients, the opportunity to do tons of surgery, fast pace, the engagement of the faculty” and more.
He started his own private practice after his fellowship. With hard work and a 24/7 schedule, he built a large practice with staff, incorporated and began running a business. Feeling good about his contributions to his hospital, he requested new imaging equipment. The request was denied, with the CFO telling Dr. Fairman, “you are a financial loser for our hospital,” because length of stay for his ruptured AAA patients was much longer than the national average. “I was a loser because my patients were surviving,” he said, astonished that this CFO didn’t understand this. He told the CFO, “If I am a financial loser, I’m outa here. … This was personal and yes, I got the equipment for our vascular lab.”
He told several patient stories, including that of one who nearly died, but whose wife refused to let Dr. Fairman give up on. Complications arose from a left-behind sponge and Dr. Fairman ultimately had to operate again. He told the couple a large settlement would certainly be theirs if they sued, which they refused to do. Indeed they sent Christmas cards for years. “This was personal,” Dr. Fairman said.
In the 1990s, with health care changing, he decided he needed to re-create his career. He returned to Penn; hospital officials, – who “had discovered I wasn’t a financial loser after all” – were not happy. And patients followed him. “It was personal and I provided a valued service,” he said.
He took advantage of a new emphasis on clinical trials that allowed researchers to advance endovascular aortic and carotid therapies, among others, and the division became nationally recognized. The specialty became interesting to him again.
A 2007 malpractice case brought him low. During this self-described “dark time,” SVS member Dr. David Gillespie put together a volunteer program to send members to Landstuhl, Germany, to provided additional vascular support for soldiers wounded in Iraq and Afghanistan. As a result of his inspiring two-week tour of duty, Dr. Fairman recovered “my sense of service, duty, and mission.” Between 2007 and 2014, 177 SVS members participated, with 28 members performing multiple tours of duty. “Talk about making it personal and commitment to service!” he said.
Dr. Fairman also discussed his efforts at Penn to discuss the financial component of worth and service, in advance of his address. The exercise was illuminating. “For every dollar we primarily generate on the inpatient side, at least another dollar is generated for other services,” he said.
He also highlighted many Society achievements and initiatives, including:
- An emphasis on quality outcomes; communicating the value of membership; practice guidelines, government relations work, and increased collaboration with other organizations.
- The relevance and value of VAM.
- A new initiative with the American College of Surgeons, the Vascular Validation Project, to create Vascular Centers of Excellence. “This will be of vital importance to the future success of our specialty and you will hear more about this over the next year,” he promised.
- Efforts for the SVS to support members who increasingly practice in outpatient centers.
- Alignment around “advocacy, practice, education, the vascular team and you, our membership.”
- Integrating community-practice members into the SVS leadership and governance.
He ended with “pearls” of advice for the younger audience, including considering their careers as a sprint, not a marathon. Collaborate when possible, but retain ownership. Don’t be afraid to make career changes and fail. Remain flexible, reinvent yourself. Don’t flip out too often (which elicited a laugh from attendees). Retain professional passion. Start new programs. Become a mentor. Remember the mission is to serve patients.
“But above all else, keep your eye on the prize, those things that keep you human and grounded and help you maintain your humility,” he said. “You will make it highly personal and you will make a difference to your patients through a career of service.”
Paraphrasing U.S. Rep. Shirley Chisholm’s quote that “Service is the rent we pay for the privilege of living on this earth,” he applied it to vascular surgeons, who have a purpose to serve patients. “Service is the rent we pay for the privilege of patient care. It is deeply personal,” he said.
“Colleagues, thank you for allowing me to be your president this past year,” he concluded. “In this highly dangerous and volatile world, may God bless all of us and our mission to our patients.”
Ronald M. Fairman, MD, held center stage Friday to present his presidential address, highlighting the personal side of vascular surgery and a career of service.
After acknowledging his family, friends, mentors, the international surgeon community, and his “family” at the University of Pennsylvania, he took the audience on “an abbreviated journey” to share events he hoped would resonate.
“Yes, it is true I was born at Penn and I am still there,” he joked. A rotation on the Penn Vascular Service led him to vascular surgery. “I was drawn to many aspects of the specialty: really sick patients, the opportunity to do tons of surgery, fast pace, the engagement of the faculty” and more.
He started his own private practice after his fellowship. With hard work and a 24/7 schedule, he built a large practice with staff, incorporated and began running a business. Feeling good about his contributions to his hospital, he requested new imaging equipment. The request was denied, with the CFO telling Dr. Fairman, “you are a financial loser for our hospital,” because length of stay for his ruptured AAA patients was much longer than the national average. “I was a loser because my patients were surviving,” he said, astonished that this CFO didn’t understand this. He told the CFO, “If I am a financial loser, I’m outa here. … This was personal and yes, I got the equipment for our vascular lab.”
He told several patient stories, including that of one who nearly died, but whose wife refused to let Dr. Fairman give up on. Complications arose from a left-behind sponge and Dr. Fairman ultimately had to operate again. He told the couple a large settlement would certainly be theirs if they sued, which they refused to do. Indeed they sent Christmas cards for years. “This was personal,” Dr. Fairman said.
In the 1990s, with health care changing, he decided he needed to re-create his career. He returned to Penn; hospital officials, – who “had discovered I wasn’t a financial loser after all” – were not happy. And patients followed him. “It was personal and I provided a valued service,” he said.
He took advantage of a new emphasis on clinical trials that allowed researchers to advance endovascular aortic and carotid therapies, among others, and the division became nationally recognized. The specialty became interesting to him again.
A 2007 malpractice case brought him low. During this self-described “dark time,” SVS member Dr. David Gillespie put together a volunteer program to send members to Landstuhl, Germany, to provided additional vascular support for soldiers wounded in Iraq and Afghanistan. As a result of his inspiring two-week tour of duty, Dr. Fairman recovered “my sense of service, duty, and mission.” Between 2007 and 2014, 177 SVS members participated, with 28 members performing multiple tours of duty. “Talk about making it personal and commitment to service!” he said.
Dr. Fairman also discussed his efforts at Penn to discuss the financial component of worth and service, in advance of his address. The exercise was illuminating. “For every dollar we primarily generate on the inpatient side, at least another dollar is generated for other services,” he said.
He also highlighted many Society achievements and initiatives, including:
- An emphasis on quality outcomes; communicating the value of membership; practice guidelines, government relations work, and increased collaboration with other organizations.
- The relevance and value of VAM.
- A new initiative with the American College of Surgeons, the Vascular Validation Project, to create Vascular Centers of Excellence. “This will be of vital importance to the future success of our specialty and you will hear more about this over the next year,” he promised.
- Efforts for the SVS to support members who increasingly practice in outpatient centers.
- Alignment around “advocacy, practice, education, the vascular team and you, our membership.”
- Integrating community-practice members into the SVS leadership and governance.
He ended with “pearls” of advice for the younger audience, including considering their careers as a sprint, not a marathon. Collaborate when possible, but retain ownership. Don’t be afraid to make career changes and fail. Remain flexible, reinvent yourself. Don’t flip out too often (which elicited a laugh from attendees). Retain professional passion. Start new programs. Become a mentor. Remember the mission is to serve patients.
“But above all else, keep your eye on the prize, those things that keep you human and grounded and help you maintain your humility,” he said. “You will make it highly personal and you will make a difference to your patients through a career of service.”
Paraphrasing U.S. Rep. Shirley Chisholm’s quote that “Service is the rent we pay for the privilege of living on this earth,” he applied it to vascular surgeons, who have a purpose to serve patients. “Service is the rent we pay for the privilege of patient care. It is deeply personal,” he said.
“Colleagues, thank you for allowing me to be your president this past year,” he concluded. “In this highly dangerous and volatile world, may God bless all of us and our mission to our patients.”
Ronald M. Fairman, MD, held center stage Friday to present his presidential address, highlighting the personal side of vascular surgery and a career of service.
After acknowledging his family, friends, mentors, the international surgeon community, and his “family” at the University of Pennsylvania, he took the audience on “an abbreviated journey” to share events he hoped would resonate.
“Yes, it is true I was born at Penn and I am still there,” he joked. A rotation on the Penn Vascular Service led him to vascular surgery. “I was drawn to many aspects of the specialty: really sick patients, the opportunity to do tons of surgery, fast pace, the engagement of the faculty” and more.
He started his own private practice after his fellowship. With hard work and a 24/7 schedule, he built a large practice with staff, incorporated and began running a business. Feeling good about his contributions to his hospital, he requested new imaging equipment. The request was denied, with the CFO telling Dr. Fairman, “you are a financial loser for our hospital,” because length of stay for his ruptured AAA patients was much longer than the national average. “I was a loser because my patients were surviving,” he said, astonished that this CFO didn’t understand this. He told the CFO, “If I am a financial loser, I’m outa here. … This was personal and yes, I got the equipment for our vascular lab.”
He told several patient stories, including that of one who nearly died, but whose wife refused to let Dr. Fairman give up on. Complications arose from a left-behind sponge and Dr. Fairman ultimately had to operate again. He told the couple a large settlement would certainly be theirs if they sued, which they refused to do. Indeed they sent Christmas cards for years. “This was personal,” Dr. Fairman said.
In the 1990s, with health care changing, he decided he needed to re-create his career. He returned to Penn; hospital officials, – who “had discovered I wasn’t a financial loser after all” – were not happy. And patients followed him. “It was personal and I provided a valued service,” he said.
He took advantage of a new emphasis on clinical trials that allowed researchers to advance endovascular aortic and carotid therapies, among others, and the division became nationally recognized. The specialty became interesting to him again.
A 2007 malpractice case brought him low. During this self-described “dark time,” SVS member Dr. David Gillespie put together a volunteer program to send members to Landstuhl, Germany, to provided additional vascular support for soldiers wounded in Iraq and Afghanistan. As a result of his inspiring two-week tour of duty, Dr. Fairman recovered “my sense of service, duty, and mission.” Between 2007 and 2014, 177 SVS members participated, with 28 members performing multiple tours of duty. “Talk about making it personal and commitment to service!” he said.
Dr. Fairman also discussed his efforts at Penn to discuss the financial component of worth and service, in advance of his address. The exercise was illuminating. “For every dollar we primarily generate on the inpatient side, at least another dollar is generated for other services,” he said.
He also highlighted many Society achievements and initiatives, including:
- An emphasis on quality outcomes; communicating the value of membership; practice guidelines, government relations work, and increased collaboration with other organizations.
- The relevance and value of VAM.
- A new initiative with the American College of Surgeons, the Vascular Validation Project, to create Vascular Centers of Excellence. “This will be of vital importance to the future success of our specialty and you will hear more about this over the next year,” he promised.
- Efforts for the SVS to support members who increasingly practice in outpatient centers.
- Alignment around “advocacy, practice, education, the vascular team and you, our membership.”
- Integrating community-practice members into the SVS leadership and governance.
He ended with “pearls” of advice for the younger audience, including considering their careers as a sprint, not a marathon. Collaborate when possible, but retain ownership. Don’t be afraid to make career changes and fail. Remain flexible, reinvent yourself. Don’t flip out too often (which elicited a laugh from attendees). Retain professional passion. Start new programs. Become a mentor. Remember the mission is to serve patients.
“But above all else, keep your eye on the prize, those things that keep you human and grounded and help you maintain your humility,” he said. “You will make it highly personal and you will make a difference to your patients through a career of service.”
Paraphrasing U.S. Rep. Shirley Chisholm’s quote that “Service is the rent we pay for the privilege of living on this earth,” he applied it to vascular surgeons, who have a purpose to serve patients. “Service is the rent we pay for the privilege of patient care. It is deeply personal,” he said.
“Colleagues, thank you for allowing me to be your president this past year,” he concluded. “In this highly dangerous and volatile world, may God bless all of us and our mission to our patients.”
Check Out the SVS Expanded Member Benefits Portfolio
The Society for Vascular Surgery has its very own member affinity program, offering members access to best-in-class products and services coupled with special member discounts.
The portfolio includes a number of insurance, financial and private-practice related products that will assist members in their day-to-day lives. The result: a selection of financial and practice solutions to protect and benefit your families, incomes, practices, offices and staff – even your own slice of cyberspace.
For more information, visit vsweb.org/AffinityProgram, call 855-533-1776 or email [email protected].
The Society for Vascular Surgery has its very own member affinity program, offering members access to best-in-class products and services coupled with special member discounts.
The portfolio includes a number of insurance, financial and private-practice related products that will assist members in their day-to-day lives. The result: a selection of financial and practice solutions to protect and benefit your families, incomes, practices, offices and staff – even your own slice of cyberspace.
For more information, visit vsweb.org/AffinityProgram, call 855-533-1776 or email [email protected].
The Society for Vascular Surgery has its very own member affinity program, offering members access to best-in-class products and services coupled with special member discounts.
The portfolio includes a number of insurance, financial and private-practice related products that will assist members in their day-to-day lives. The result: a selection of financial and practice solutions to protect and benefit your families, incomes, practices, offices and staff – even your own slice of cyberspace.
For more information, visit vsweb.org/AffinityProgram, call 855-533-1776 or email [email protected].
Political Action Committee Reception Is Thursday
A meal and conversation with Rep. Paul Ryan (R-WI), Speaker of the U.S. House of Representatives. An existing relationship with Dr. Tom Price, now secretary of the U.S. Department of Health & Human Services. Working relationships with others in office who make national health care decisions affecting SVS members. Such benefits happen because of the SVS Political Action Committee.
The SVS PAC works for vascular surgeons – ONLY vascular surgeons – to ensure SVS access to U.S. representatives and senators to discuss issues that have a major impact on members and their patients. Contributions help elect or re-elect candidates who can be helpful with such issues.
The SVS PAC will hold a reception and “thank you” for those donors who have contributed to the PAC since Jan. 1, 2016. This includes donations received during the 2017 Vascular Annual Meeting.
The reception will be held from 7:00 to 8:30 p.m. Thursday, June 1, in the La Costa Room at the Marriott Marquis.
Contributions are critically important to the future of members, their profession and their practices, PAC leaders say.
“A good offense – great advocacy – is the best defense when confronted with so many unknowns today,” said Carlo A. Dall’Olmo, former SVS PAC chair. “The challenges are obvious, and they are present on both sides of the aisle. … (contributions) to the SVS/PAC will allow us to advocate at every opportunity.”
Thursday, June 1
7:00 – 8:30 p.m.
Marriott Marquis, La Costa Room
South Tower, fourth floor
PAC Reception
A meal and conversation with Rep. Paul Ryan (R-WI), Speaker of the U.S. House of Representatives. An existing relationship with Dr. Tom Price, now secretary of the U.S. Department of Health & Human Services. Working relationships with others in office who make national health care decisions affecting SVS members. Such benefits happen because of the SVS Political Action Committee.
The SVS PAC works for vascular surgeons – ONLY vascular surgeons – to ensure SVS access to U.S. representatives and senators to discuss issues that have a major impact on members and their patients. Contributions help elect or re-elect candidates who can be helpful with such issues.
The SVS PAC will hold a reception and “thank you” for those donors who have contributed to the PAC since Jan. 1, 2016. This includes donations received during the 2017 Vascular Annual Meeting.
The reception will be held from 7:00 to 8:30 p.m. Thursday, June 1, in the La Costa Room at the Marriott Marquis.
Contributions are critically important to the future of members, their profession and their practices, PAC leaders say.
“A good offense – great advocacy – is the best defense when confronted with so many unknowns today,” said Carlo A. Dall’Olmo, former SVS PAC chair. “The challenges are obvious, and they are present on both sides of the aisle. … (contributions) to the SVS/PAC will allow us to advocate at every opportunity.”
Thursday, June 1
7:00 – 8:30 p.m.
Marriott Marquis, La Costa Room
South Tower, fourth floor
PAC Reception
A meal and conversation with Rep. Paul Ryan (R-WI), Speaker of the U.S. House of Representatives. An existing relationship with Dr. Tom Price, now secretary of the U.S. Department of Health & Human Services. Working relationships with others in office who make national health care decisions affecting SVS members. Such benefits happen because of the SVS Political Action Committee.
The SVS PAC works for vascular surgeons – ONLY vascular surgeons – to ensure SVS access to U.S. representatives and senators to discuss issues that have a major impact on members and their patients. Contributions help elect or re-elect candidates who can be helpful with such issues.
The SVS PAC will hold a reception and “thank you” for those donors who have contributed to the PAC since Jan. 1, 2016. This includes donations received during the 2017 Vascular Annual Meeting.
The reception will be held from 7:00 to 8:30 p.m. Thursday, June 1, in the La Costa Room at the Marriott Marquis.
Contributions are critically important to the future of members, their profession and their practices, PAC leaders say.
“A good offense – great advocacy – is the best defense when confronted with so many unknowns today,” said Carlo A. Dall’Olmo, former SVS PAC chair. “The challenges are obvious, and they are present on both sides of the aisle. … (contributions) to the SVS/PAC will allow us to advocate at every opportunity.”
Thursday, June 1
7:00 – 8:30 p.m.
Marriott Marquis, La Costa Room
South Tower, fourth floor
PAC Reception
Before the Parade Passes By, Be Sure to Cross the Street
Are we in Pamplona, Spain, or San Diego, California?
The differences might blur Saturday morning; it won’t be Pamplona’s running of the bulls in front of the San Diego Convention Center, but a cattle drive of long-horned cattle. And this frontier drive may create a few difficulties getting to and from the Vascular Annual Meeting.
The cattle will travel on Harbor Drive, the street directly in front of the San Diego Convention Center, VAM’s home and the VAM headquarters hotel, the Marriot Marquis San Diego Marina.
The route will affect the ability to cross Harbor Drive (from other hotels, for example) and will delay anyone attempting to leave the Marriott via car or taxi while the parade is passing by.
For those staying in San Diego after VAM, the fair opens June 2 and runs through July 4. Fun includes panning for gold, a Wild West saloon with an old-fashioned player piano, and chance encounters with notorious outlaws such as Jesse James and Black Bart.
Are we in Pamplona, Spain, or San Diego, California?
The differences might blur Saturday morning; it won’t be Pamplona’s running of the bulls in front of the San Diego Convention Center, but a cattle drive of long-horned cattle. And this frontier drive may create a few difficulties getting to and from the Vascular Annual Meeting.
The cattle will travel on Harbor Drive, the street directly in front of the San Diego Convention Center, VAM’s home and the VAM headquarters hotel, the Marriot Marquis San Diego Marina.
The route will affect the ability to cross Harbor Drive (from other hotels, for example) and will delay anyone attempting to leave the Marriott via car or taxi while the parade is passing by.
For those staying in San Diego after VAM, the fair opens June 2 and runs through July 4. Fun includes panning for gold, a Wild West saloon with an old-fashioned player piano, and chance encounters with notorious outlaws such as Jesse James and Black Bart.
Are we in Pamplona, Spain, or San Diego, California?
The differences might blur Saturday morning; it won’t be Pamplona’s running of the bulls in front of the San Diego Convention Center, but a cattle drive of long-horned cattle. And this frontier drive may create a few difficulties getting to and from the Vascular Annual Meeting.
The cattle will travel on Harbor Drive, the street directly in front of the San Diego Convention Center, VAM’s home and the VAM headquarters hotel, the Marriot Marquis San Diego Marina.
The route will affect the ability to cross Harbor Drive (from other hotels, for example) and will delay anyone attempting to leave the Marriott via car or taxi while the parade is passing by.
For those staying in San Diego after VAM, the fair opens June 2 and runs through July 4. Fun includes panning for gold, a Wild West saloon with an old-fashioned player piano, and chance encounters with notorious outlaws such as Jesse James and Black Bart.
How to Welcome a Patient Advisor to Your Research Team
When it comes to caring for those with vascular disease, who better to tell surgeons and researchers the effects of various treatments than … patients?
Patients who have completed a comprehensive Patient Advisors Course will provide their perspective Thursday afternoon in “Patient Advisors Program,” 2:30 to 3:30 p.m., with a reception to further the conversation immediately afterward, from 3:30 to 4:30 p.m.
This session has been more than a year in the making, the fruition of a project funded by the Patient-Centered Outcomes Research Institute on “Connecting Patients and Researchers to Engage in Patient-Centered Vascular Disease Research.” Adrienne Faerber, PhD, at the Dartmouth Institute for Health Policy and Clinical Research is leading the project in partnership with SVS member Philip Goodney, MD.
The patients attending VAM have completed an online course aimed at patient collaboration with researchers and clinicians. Researchers, clinicians, and clinical leaders all should find the session valuable, said Dr. Faerber. Major funding agencies are moving toward requiring patients to give their input on research proposals, she said.
“And clinicians who want to improve their care of patients and clinical leaders who want to learn about leading change initiatives will want to listen to what they have to say as well.
“Patients are the experts in living with vascular diseases and we should be listening to them.”
Their experience encompasses far more than just their treatment, Dr. Faerber said of patients, with questions – even if they don’t know to ask them – that involve far more than “stent or surgery.”
“Surgeons tend to think of risks and benefits of procedures. But patients find the post-operative recovery a really important part of the experience,” she said. Surgeons should discuss pain management and any lifestyle restrictions; for example, a patient might not know until after surgery that he cannot drive for six or eight weeks.
“In the patient-centered view, that’s a huge issue,” she said.
“Providing good care goes beyond recommending a treatment,” said Dr. Faerber. “Clinicians need their patients’ input as to what they want, their values and beliefs.” Considering all those factors, plus lifestyle, “may change your thinking on the treatment decision.”
The Thursday session includes an orientation to patient-centered research and patient advisors, conversations with patients about their experiences and how clinics and hospitals can improve the patient experience of those with vascular care plus clinician and researcher reactions.
Dr. Matthew Corriere will discuss parallels between the patients’ stories to his work evaluating what matters to patients undergoing treatment, and Dr. Philip Goodney will describe how patient advisors have helped him improve his research portfolio.
The reception following the session will provide an opportunity to talk with the patient advisors and find out more about adding a Patient Advisor to a research or quality improvement team.
For more information, visit patientadvisorscourse.com.
Thursday, June 1
2:30 – 3:30 p.m.
SDCC, Room 17B
Patient Advisors Program
Moderators: Adrienne Faerber, PhD and Philip Goodney, MD
3:30 – 4:30 p.m.
SDCC, Room 17B
Patient Advisors Program Reception
When it comes to caring for those with vascular disease, who better to tell surgeons and researchers the effects of various treatments than … patients?
Patients who have completed a comprehensive Patient Advisors Course will provide their perspective Thursday afternoon in “Patient Advisors Program,” 2:30 to 3:30 p.m., with a reception to further the conversation immediately afterward, from 3:30 to 4:30 p.m.
This session has been more than a year in the making, the fruition of a project funded by the Patient-Centered Outcomes Research Institute on “Connecting Patients and Researchers to Engage in Patient-Centered Vascular Disease Research.” Adrienne Faerber, PhD, at the Dartmouth Institute for Health Policy and Clinical Research is leading the project in partnership with SVS member Philip Goodney, MD.
The patients attending VAM have completed an online course aimed at patient collaboration with researchers and clinicians. Researchers, clinicians, and clinical leaders all should find the session valuable, said Dr. Faerber. Major funding agencies are moving toward requiring patients to give their input on research proposals, she said.
“And clinicians who want to improve their care of patients and clinical leaders who want to learn about leading change initiatives will want to listen to what they have to say as well.
“Patients are the experts in living with vascular diseases and we should be listening to them.”
Their experience encompasses far more than just their treatment, Dr. Faerber said of patients, with questions – even if they don’t know to ask them – that involve far more than “stent or surgery.”
“Surgeons tend to think of risks and benefits of procedures. But patients find the post-operative recovery a really important part of the experience,” she said. Surgeons should discuss pain management and any lifestyle restrictions; for example, a patient might not know until after surgery that he cannot drive for six or eight weeks.
“In the patient-centered view, that’s a huge issue,” she said.
“Providing good care goes beyond recommending a treatment,” said Dr. Faerber. “Clinicians need their patients’ input as to what they want, their values and beliefs.” Considering all those factors, plus lifestyle, “may change your thinking on the treatment decision.”
The Thursday session includes an orientation to patient-centered research and patient advisors, conversations with patients about their experiences and how clinics and hospitals can improve the patient experience of those with vascular care plus clinician and researcher reactions.
Dr. Matthew Corriere will discuss parallels between the patients’ stories to his work evaluating what matters to patients undergoing treatment, and Dr. Philip Goodney will describe how patient advisors have helped him improve his research portfolio.
The reception following the session will provide an opportunity to talk with the patient advisors and find out more about adding a Patient Advisor to a research or quality improvement team.
For more information, visit patientadvisorscourse.com.
Thursday, June 1
2:30 – 3:30 p.m.
SDCC, Room 17B
Patient Advisors Program
Moderators: Adrienne Faerber, PhD and Philip Goodney, MD
3:30 – 4:30 p.m.
SDCC, Room 17B
Patient Advisors Program Reception
When it comes to caring for those with vascular disease, who better to tell surgeons and researchers the effects of various treatments than … patients?
Patients who have completed a comprehensive Patient Advisors Course will provide their perspective Thursday afternoon in “Patient Advisors Program,” 2:30 to 3:30 p.m., with a reception to further the conversation immediately afterward, from 3:30 to 4:30 p.m.
This session has been more than a year in the making, the fruition of a project funded by the Patient-Centered Outcomes Research Institute on “Connecting Patients and Researchers to Engage in Patient-Centered Vascular Disease Research.” Adrienne Faerber, PhD, at the Dartmouth Institute for Health Policy and Clinical Research is leading the project in partnership with SVS member Philip Goodney, MD.
The patients attending VAM have completed an online course aimed at patient collaboration with researchers and clinicians. Researchers, clinicians, and clinical leaders all should find the session valuable, said Dr. Faerber. Major funding agencies are moving toward requiring patients to give their input on research proposals, she said.
“And clinicians who want to improve their care of patients and clinical leaders who want to learn about leading change initiatives will want to listen to what they have to say as well.
“Patients are the experts in living with vascular diseases and we should be listening to them.”
Their experience encompasses far more than just their treatment, Dr. Faerber said of patients, with questions – even if they don’t know to ask them – that involve far more than “stent or surgery.”
“Surgeons tend to think of risks and benefits of procedures. But patients find the post-operative recovery a really important part of the experience,” she said. Surgeons should discuss pain management and any lifestyle restrictions; for example, a patient might not know until after surgery that he cannot drive for six or eight weeks.
“In the patient-centered view, that’s a huge issue,” she said.
“Providing good care goes beyond recommending a treatment,” said Dr. Faerber. “Clinicians need their patients’ input as to what they want, their values and beliefs.” Considering all those factors, plus lifestyle, “may change your thinking on the treatment decision.”
The Thursday session includes an orientation to patient-centered research and patient advisors, conversations with patients about their experiences and how clinics and hospitals can improve the patient experience of those with vascular care plus clinician and researcher reactions.
Dr. Matthew Corriere will discuss parallels between the patients’ stories to his work evaluating what matters to patients undergoing treatment, and Dr. Philip Goodney will describe how patient advisors have helped him improve his research portfolio.
The reception following the session will provide an opportunity to talk with the patient advisors and find out more about adding a Patient Advisor to a research or quality improvement team.
For more information, visit patientadvisorscourse.com.
Thursday, June 1
2:30 – 3:30 p.m.
SDCC, Room 17B
Patient Advisors Program
Moderators: Adrienne Faerber, PhD and Philip Goodney, MD
3:30 – 4:30 p.m.
SDCC, Room 17B
Patient Advisors Program Reception
See Photos from VRIC
This year we have photographic proof – VRIC is a great experience for researchers. Invigorating discussions, great speakers, inspiration, new ideas – it was all part of the Vascular Research Initiatives Conference in Minneapolis. See our photo album on Flickr or watch the slide show version on YouTube.
This year we have photographic proof – VRIC is a great experience for researchers. Invigorating discussions, great speakers, inspiration, new ideas – it was all part of the Vascular Research Initiatives Conference in Minneapolis. See our photo album on Flickr or watch the slide show version on YouTube.
This year we have photographic proof – VRIC is a great experience for researchers. Invigorating discussions, great speakers, inspiration, new ideas – it was all part of the Vascular Research Initiatives Conference in Minneapolis. See our photo album on Flickr or watch the slide show version on YouTube.
Going to VAM? Don’t Forget the Mobile App
Have VAM at your fingertips with the Mobile App. You can:
- Take your MOC assessment tests via a link within the app
- Access all abstracts, schedules and speaker bios
- Create your own agenda of sessions and events
- Bookmark abstracts of interest
- View maps
- View attendees and private message them
- Share photos and status updates …
- ... and much more
There’s a version for iPhones and one for Android phones.
Have VAM at your fingertips with the Mobile App. You can:
- Take your MOC assessment tests via a link within the app
- Access all abstracts, schedules and speaker bios
- Create your own agenda of sessions and events
- Bookmark abstracts of interest
- View maps
- View attendees and private message them
- Share photos and status updates …
- ... and much more
There’s a version for iPhones and one for Android phones.
Have VAM at your fingertips with the Mobile App. You can:
- Take your MOC assessment tests via a link within the app
- Access all abstracts, schedules and speaker bios
- Create your own agenda of sessions and events
- Bookmark abstracts of interest
- View maps
- View attendees and private message them
- Share photos and status updates …
- ... and much more
There’s a version for iPhones and one for Android phones.
Are you prepared for MACRA?
MACRA (Medicare Access and CHIP Reauthorization Act of 2015) replaces the flawed sustainable growth rate (SGR) formula and significantly changes the way Medicare pays physicians.
Many things about the Affordable Care Act (ACA; Obamacare) are likely to change under the new administration, but MACRA and the commitment to cost-effective, value-based care is here to stay. MACRA is separate from the ACA. Congress overwhelmingly passed MACRA legislation with bipartisan support. MACRA will eventually transition physicians toward more value-based payments.
It is important to understand MACRA to ensure you are doing everything required under the current rules in 2017. Ignore MACRA in 2017 and you will face an automatic reduction of 4% to your payments under Medicare in 2019.
AGA offers educational webinars and videos to help you prepare. Visit gastro.org/MACRA to learn more.
MACRA (Medicare Access and CHIP Reauthorization Act of 2015) replaces the flawed sustainable growth rate (SGR) formula and significantly changes the way Medicare pays physicians.
Many things about the Affordable Care Act (ACA; Obamacare) are likely to change under the new administration, but MACRA and the commitment to cost-effective, value-based care is here to stay. MACRA is separate from the ACA. Congress overwhelmingly passed MACRA legislation with bipartisan support. MACRA will eventually transition physicians toward more value-based payments.
It is important to understand MACRA to ensure you are doing everything required under the current rules in 2017. Ignore MACRA in 2017 and you will face an automatic reduction of 4% to your payments under Medicare in 2019.
AGA offers educational webinars and videos to help you prepare. Visit gastro.org/MACRA to learn more.
MACRA (Medicare Access and CHIP Reauthorization Act of 2015) replaces the flawed sustainable growth rate (SGR) formula and significantly changes the way Medicare pays physicians.
Many things about the Affordable Care Act (ACA; Obamacare) are likely to change under the new administration, but MACRA and the commitment to cost-effective, value-based care is here to stay. MACRA is separate from the ACA. Congress overwhelmingly passed MACRA legislation with bipartisan support. MACRA will eventually transition physicians toward more value-based payments.
It is important to understand MACRA to ensure you are doing everything required under the current rules in 2017. Ignore MACRA in 2017 and you will face an automatic reduction of 4% to your payments under Medicare in 2019.
AGA offers educational webinars and videos to help you prepare. Visit gastro.org/MACRA to learn more.
2018 AGA Fellows Program now accepting applications
The application period for the 2018 AGA Fellows Program is now open. The program recognizes members whose accomplishments demonstrate personal commitment to the field of gastroenterology with the distinction of fellowship.
AGA Fellows receive this honor from AGA for their superior professional achievement in clinical private or academic practice and in basic or clinical research.
AGA Fellows receive:
- The privilege of using the designation “AGAF” in professional activities.
- An official certificate and pin denoting your status.
- A listing on the AGA website.
And more.
Apply today to join this international community of excellence.
Find more information, including the list of benefits and criteria for fellowship, at www.gastro.org/fellowship. The deadline for application submissions is Monday, July 31, 2017.
The application period for the 2018 AGA Fellows Program is now open. The program recognizes members whose accomplishments demonstrate personal commitment to the field of gastroenterology with the distinction of fellowship.
AGA Fellows receive this honor from AGA for their superior professional achievement in clinical private or academic practice and in basic or clinical research.
AGA Fellows receive:
- The privilege of using the designation “AGAF” in professional activities.
- An official certificate and pin denoting your status.
- A listing on the AGA website.
And more.
Apply today to join this international community of excellence.
Find more information, including the list of benefits and criteria for fellowship, at www.gastro.org/fellowship. The deadline for application submissions is Monday, July 31, 2017.
The application period for the 2018 AGA Fellows Program is now open. The program recognizes members whose accomplishments demonstrate personal commitment to the field of gastroenterology with the distinction of fellowship.
AGA Fellows receive this honor from AGA for their superior professional achievement in clinical private or academic practice and in basic or clinical research.
AGA Fellows receive:
- The privilege of using the designation “AGAF” in professional activities.
- An official certificate and pin denoting your status.
- A listing on the AGA website.
And more.
Apply today to join this international community of excellence.
Find more information, including the list of benefits and criteria for fellowship, at www.gastro.org/fellowship. The deadline for application submissions is Monday, July 31, 2017.